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AUTHOR’S VIEW
BRCA1-BARD1: the importance of being in shape
Manuel Daza-Martin *, Ruth M. Densham , and Joanna R. Morris
Birmingham Centre for Genome Biology and Institute of Cancer and Genomics Sciences, University of Birmingham, Birmingham, UK
ABSTRACT
The breast cancer type-1 susceptibility protein (BRCA1) contributes to genome integrity through homo-
logous recombinational DNA repair and by protecting stalled replication forks from nucleolytic degradation.
We recently discovered that fork protection requires a conformational change of BRCA1 unimportant to
homologous recombination repair, indicating separate roles for BRCA1 in these pathways.
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Authors view
The breast cancer type-1 susceptibility protein (BRCA1) has
a well-established role in directing the repair of DNA double
strand breaks through homologous recombination (HR).
BRCA1 both promotes resection and contributes to the associa-
tion of the partner and localizer of BRCA2 (PALB2) with the
breast cancer type-2 susceptibility protein (BRCA2) to sites of
DNA damage, where the PALB2-BRCA2 complex acts to
exchange the single stranded DNA (ssDNA) binding replication
protein A complex (RPA) for the DNA repair protein RAD51
homolog 1. This exchange generates a RAD51-nucleofilament
which subsequently performs strand invasion and synapse forma-
tion required for gene conversion. It is now also clear that when
replication forks stall, BRCA1 plays a role in the protection of
newly synthesized DNA from excessive resection: a process that
also requires key HR factors including BRCA2, Fanconi Anemia
complementation group D2 (FANCD2), and most significantly
RAD51 (reviewed in1). Replication may stall at roadblocks or
collisions formed between the transcription and replication
machinery; at difficult to replicate regions, such as repetitive
sequences or secondary DNA structures; or due to nucleotide
shortages. While nuclease activity is required at reversed forks to
resumeDNA replication, uncontrolled resection is correlated with
genome instability. However, nascent strand loss mediated
by Meiotic recombination 11 homolog 1 (MRE11) and DNA
replication ATP-dependent helicase/nuclease DNA2 can be pre-
vented by loading RAD51 at exposed ssDNA.
Given that many of the proteins required to promote
RAD51:RPA exchange in HR are also required for limiting
the degradation of stalled replication forks one might assume
that the role of BRCA1 in both processes would be related.
However, our recent work found that while both BRCA1 and
PALB2 are required to protect nascent DNA following hydro-
xyurea-induced replication fork stalling, their canonical inter-
action, important in HR, is dispensable.2 PALB2 can be
recruited through RING finger protein 168 (RNF168) or
through phosphorylated RPA3,4 and we speculate that these
mechanisms, rather than recruitment through BRCA1, may
predominate at stalled replication forks.
We found that the role of BRCA1 in fork protection relates to
direct RAD51 interaction which is regulated through a series of
post-translational events (Figure 1). We identified that phosphor-
ylation of BRCA1 at serine 114 (S114) is required for fork protec-
tion but has no measurable impact on fork stalling, fork restart or
features of HR.2 Phosphorylation of S114-BRCA1 requires cyclin-
dependent kinases 1/2 (CDK1/2) and the phosphorylated BRCA1
region forms the main binding site for the phosphorylation-
targeted peptidyl-prolyl cis-trans isomerase NIMA-interacting 1
(PIN1). PIN1 catalyzes the cis-trans isomerization of peptidyl
bonds between phosphorylated serine/threonine and proline resi-
dues, resulting in subtle or significant conformational alterations
of its substrates. In the case of BRCA1 and its heterodimeric
binding partner BRCA1-associated RING domain protein 1
(BARD1), PIN1 acts to increase the accessibility of the RAD51
binding pocket on BARD1 (identified recently5), enhancing the
ability of the heterodimer to bind RAD51.
Cells expressing a C-terminal BRCA2 mutation that inhibits
fork protection, but that has no defect in HR, show genomic
instability.6 Likewise we noted that cells with mutation of
BRCA1-S114 that exhibit poor fork protection, but adequate
HR, showed increased chromosomal breaks, which we imagine
arise from the processing of stalled, de-protected structures.
TheBARD1-RAD51binding face onRAD51overlapswith that
of the BRCA2-RAD51 interaction face5 suggesting either that the
total RAD51 needed at stalled forks interacts with BRCA1 and
BRCA2 independently or that there is a hand-off between BRCA1
andBRCA2 reflecting different temporal needs during the process.
Loss of chromodomain-helicase-DNA-binding protein 4 (CHD4)
rescues fork protection defects in BRCA2-deficient cells yet does
not restore protection to cells lacking BRCA1,7 while loss of RB
binding protein-8/CtBP-interacting protein (RBBP8 commonly
known as CtIP), which is epistatic with BRCA2 loss, further
worsens fork protection in BRCA1-deficient cells.8 These
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observations are consistent with an ‘independent RAD51 popula-
tions’ model. However as yet there have been no reports of factor
losses that rescue the need for BRCA1 but not BRCA2 in fork
protection, perhaps suggesting a hierarchy, BRCA1>BRCA2, con-
sistent with hand-off. The BRCA2C-terminus binds and stabilizes
oligomeric RAD51 and we speculate that the conformational
change in BRCA1 may allow BRCA1-BARD1 to contribute
a similar function.
CDK activity and PIN1 regulation are not sufficient to
explain the observed recruitment of pS114-BRCA1 to stalled
forks. It seems likely that the recently described interaction of
BARD1 with newly made chromatin9 and BARD1 interaction
with poly-ADP-ribose (PAR),10 present at stalled forks, con-
tributes to heterodimer recruitment.
While RAD51-mediated preservation of nascent DNA at
stalled forks is important to prevent chromosome damage,
increased RAD51 at replication forks results in fork collapse and
increased DNA breaks in unperturbed replication. We found that
constitutive expression of a trans-favored form of BRCA1 simi-
larly accelerated accumulation of DNA damage, suggesting that
constitutive presentation of BRCA1-BARD1 primed for RAD51
interaction is dangerous. Murine Brca1 has a cysteine at the
position equivalent to the PIN1 targeted proline of human
BRCA1 so that the murine protein is likely to be constitutively
present in a trans-favored form. Whether murine cells are more
tolerant to Rad51 at replication forks or have another regulatory
pathway remains a significant question.
Intriguingly, the regions surrounding the RAD51 binding
region of BARD1 and the phosphorylation and PIN1 interac-
tion region of BRCA1 contain a number of somatic and
germline genetic cancer associated variants, some of which
exhibit deficient fork protection without showing features of
an HR-deficit. Whether impaired fork protection is enough to
drive cancer development is not yet clear, but appears doubt-
ful in view of a recent analysis of a murine Bard1-C-terminal
mutant that exhibits poor fork protection, but shows no
increased cancer development.10 Restoration of fork protec-
tion has recently emerged as means of resistance to HR-
directed therapies in BRCA1/2-mutant cancers1 so that resol-
ving the order and dependencies of BRCA1:BRCA2 and other
critical ‘HR’ proteins in this pathway will be important to
patient care.
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Figure 1. Phosphorylation and isomerization of BRCA1 promotes replication fork protection. Illustration of the post-translational modifications that regulate the
heterodimeric breast cancer type-1 susceptibility protein (BRCA1) (green) and BRCA1-associated RING domain protein 1 (BARD1) (orange) complex. Cyclin-dependent
kinases 1/2 (CDK1/2) (pink) phosphorylate BRCA1 at serine 114 which is bound by the peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 (PIN1) (purple) to
promote isomerization and improve the interaction with DNA repair protein RAD51 homolog 1 (RAD51) (blue) required for replication fork protection.
BARD1 BRCA1-associated RING domain protein 1
BRCA1 breast cancer type-1 susceptibility protein
BRCA2 breast cancer type-2 susceptibility protein
CDK1/2 cyclin-dependent kinases 1/2
CHD4 chromodomain-helicase-DNA-binding protein 4
CtIP CtBP-interacting protein
DNA2 DNA replication ATP-dependent helicase/nuclease
FANCD2 Fanconi Anemia complementation group D2
HR homologous recombination
MRE11 Meiotic recombination 11 homolog 1
PALB2 partner and localizer of BRCA2
PAR poly-ADP-ribose
PIN1 peptidyl-prolyl cis-trans isomerase NIMA-interacting 1
RAD51 DNA repair protein RAD51 homolog 1
RBBP8 RB binding protein-8
RNF168 RING-finger protein 168
RPA replication protein A
ssDNA single stranded DNA
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